Advertisement Haselmeier Announces the Market Launch of JuniorSTAR® by Sanofi - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Haselmeier

Self-Injection Devices Developer and Manufacturer

More info about Haselmeier

Haselmeier Announces the Market Launch of JuniorSTAR® by Sanofi

"The launch of JuniorSTAR® marks another milestone of a long-term partnership with Sanofi.After the single unit pen TactiPen®, the portfolio is now completed by the half-unit pen JuniorSTAR®. The JuniorSTAR® delivers 1 to 30 units in steps of 0.5. Thanks to the close cooperation of both teams we were able to develop an excellent pen which meets the current very high quality requirements." explains Sandra de Haan, Director Project Management at Haselmeier and responsible project manager for the JuniorSTAR® project.

"The JuniorSTAR® expands our individual portfolio for people suffering from diabetes. This pen offers, especially young people with type 1 diabetes, a flexible and easy handling to lighten their lives with diabetes. The excellent and close cooperation with Haselmeier was an important part for the successful development of the JuniorSTAR® pen." explains Hamit Oualali, Global Device Manager for reusable pens at Sanofi.

This pen comes in red, blue and silver for more flexibility and easy differentiation of various insulin types. The Chicago Athenaeum, Museum of Architecture and Design already honoured the JuniorSTAR® pen for its new and fully developed technology with the Good Design Award.

Quick Contact

Top Products from Haselmeier